From risk to action: Preventing liver health crises through NCD literacy and care 

Liver health is a growing public health priority in Europe, with chronic liver diseases and liver cancer placing increasing strain on patients, health systems, and economies.

Despite being largely preventable, liver conditions often go undetected until advanced stages, underscoring the urgent need for early detection, better care coordination, and stronger public awareness.

Through focused discussions and real-life testimonials, we will examine the challenges of managing comorbidities, the role of patient organisations in shaping care pathways, and how EU initiatives and policies can support innovative solutions, from prevention to treatment, especially in the fight against liver cancer.

Interested in this event?

Event Details

- What are the key challenges patients face in managing multiple chronic conditions?

- How can patient organisations contribute to better care coordination and more comprehensive treatment strategies for individuals with comorbidities?

- In what ways can empowering patients and strengthening patient organisations lead to meaningful improvements in healthcare systems?

Can liver cancer be prevented before it starts? These expert talks reveal how lifestyle, early detection, and smart policy can prevent liver disease and other major killers - and why prevention may be our strongest tool yet.

Can liver cancer be prevented before it starts? These expert talks reveal how lifestyle, early detection, and smart policy can prevent liver disease and other major killers - and why prevention may be our strongest tool yet.

- What urgent steps are needed to improve its early detection and treatment across Europe?

- How can integrated healthcare strategies address the link between chronic liver conditions and liver cancer within the broader non-communicable disease (NCD) framework?

- How can public health education and improved health literacy help individuals and communities take proactive steps to prevent the progression of chronic diseases?

- What important legislative actions and funds are required to support long-term health promotion and disease prevention programs at the EU level?

- How can EU policymakers improve cooperation between Member States and stakeholder engagement to ensure cohesive, inclusive, and effective public health policies?

- What role can innovation, such as data-driven care, targeted therapies, and expanded screening programmes, play in advancing public health outcomes?

Program Director, Liver Health is Public Health
Global Liver Institute (GLI)
Hepatologist
Barcelona Institute of Digestive and Metabolic Diseases
(ECR, Lithuania)
European Parliament
Policy & Practice Officer
EuroHealthNet
Member of EASL Public Health, Policy and Advocacy Committee
EASL
Director General
European Public Health Alliance
Professor of Medicine
Erasmus MC University Rotterdam
Co-Founder
Liver4Life
President
European Patients' Forum
Chair of the Board
Cancer Patients Europe
Epidemiologist
International Agency for Research on Cancer - World Health Organization
President
The European Association for the Study of Obesity
Public Affairs Group Chair
United European Gastroenterology
Associate Professor of Medicine
Erasmus MC, Rotterdam
Associate Professor
Department of Brain and Behavioural Sciences - University of Pavia
Board Director
European Liver Patients' Association
President
European Liver Patients' Association
(S&D, Greece)
European Parliament
(S&D, Lithuania)
European Parliament
MD & Independent Journalist
MEP (EPP, Hungary)
European Parliament
(EPP, Croatia)
European Parliament
Event Details
    Sponsors